Martins Metelo et al., 2015
- Pharmacological HIF2α inhibition improves VHL diseaseāassociated phenotypes in zebrafish model.
J. Clin. Invest.
125(5):1987-97
Full text @ J. Clin. Invest.
| Marker Type | Symbol | Name |
|---|---|---|
| Gene | angpt1 | angiopoietin 1 |
| Gene | egln3 | egl-9 family hypoxia-inducible factor 3 |
| Gene | epas1a | endothelial PAS domain protein 1a |
| Gene | epas1b | endothelial PAS domain protein 1b |
| Gene | epoa | erythropoietin a |
| Gene | hif1aa | hypoxia inducible factor 1 subunit alpha a |
| Gene | hif1ab | hypoxia inducible factor 1 subunit alpha b |
| Gene | myb | MYB proto-oncogene, transcription factor |
| Gene | tfa | transferrin-a |
| Gene | tgfa | transforming growth factor, alpha |
| Gene | vegfab | vascular endothelial growth factor Ab |
| Gene | vhl | von Hippel-Lindau tumor suppressor |